Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
74
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Waters
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Pharmaceutical R&D And Merger Will Unlock Future Market Potential
Key Takeaways Growth is supported by strong pharma sector expansion, deeper market penetration, and enhanced pricing power from new product launches and partnerships. Broadened revenue streams, recurring sales, and operational efficiencies position the company for stable margins and robust long-term earnings growth.
View narrative
US$358.35
FV
21.5% undervalued
intrinsic discount
6.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
4 days ago
author updated this narrative
Gilead Sciences
AN
AnalystHighTarget
Consensus Narrative from 25 Analysts
Lenacapavir And Trodelvy Launches Will Serve A Growing Aging Market
Key Takeaways Multiple new product launches and innovation in oncology and HIV therapy strongly position Gilead to expand into larger, diversified markets and drive sustained revenue growth. Strength in core HIV and liver portfolios, robust R&D, and minimal competition risks support stable cash flows and enable long-term margin and earnings expansion.
View narrative
US$140.00
FV
14.7% undervalued
intrinsic discount
5.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Analog Devices
AN
AnalystHighTarget
Consensus Narrative from 32 Analysts
IoT, Electric Vehicles And Digital Health Will Expand Markets
Key Takeaways Growth in industrial automation, automotive sensing, and edge intelligence is driving long-term revenue streams and higher margins through innovative, high-density, low-power solutions. Strategic expansion into digital healthcare, AI infrastructure, and advanced manufacturing enhances market share, operational resilience, and profitability across multiple high-growth sectors.
View narrative
US$300.00
FV
25.4% undervalued
intrinsic discount
16.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Bristol-Myers Squibb
AN
AnalystHighTarget
Consensus Narrative from 21 Analysts
Pipeline Launches And Global Healthcare Trends Will Unlock Growth
Key Takeaways Robust portfolio performance and pipeline innovation, especially in immuno-oncology, are fueling faster-than-expected revenue growth and international market expansion. Strong cost discipline, operational efficiencies, and AI-driven R&D enhancements are creating substantial upside for margins and long-term earnings growth.
View narrative
US$68.00
FV
32.4% undervalued
intrinsic discount
-2.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Zoom Communications
AN
AnalystConsensusTarget
Consensus Narrative from 27 Analysts
Custom AI Companion May Boost Productivity But Faces Adoption Uncertainties
Key Takeaways Zoom's shift to an AI-first platform and agentic AI capabilities could enhance customer productivity and create new revenue opportunities. Strategic partnerships and enterprise market focus aim to expand user base and enterprise growth, improving revenue and margins.
View narrative
US$91.07
FV
21.4% undervalued
intrinsic discount
3.27%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
3
users have commented on this narrative
62
users have followed this narrative
4 days ago
author updated this narrative
Regeneron Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 22 Analysts
Dupixent And EYLEA Will Seize Expanding Global Markets
Key Takeaways Regeneron's best-in-class therapies, strong product adoption, and innovative pipeline position it for rapid market share gains and expanded, diversified long-term growth. Strategic investments in manufacturing and advanced biologics platforms enable operational efficiency, robust supply, and capitalize on rising global demand for precision medicines.
View narrative
US$913.96
FV
38.4% undervalued
intrinsic discount
7.59%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
DraftKings
AN
AnalystConsensusTarget
Consensus Narrative from 33 Analysts
US Gaming Legalization Will Expand Future Opportunities In Live Betting And Digital Lottery
Key Takeaways Expansion of online gaming legalization in more states could significantly boost DraftKings' revenue and growth prospects. Leveraging expertise in live betting and new verticals like digital lottery could enhance customer engagement and future revenue.
View narrative
US$53.59
FV
20.0% undervalued
intrinsic discount
22.27%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
76
users have followed this narrative
4 days ago
author updated this narrative
Genuine Parts
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Digital Investments And Global Expansion Will Reshape Auto Parts Distribution
Key Takeaways Aging global vehicle fleets and rising vehicle complexity support sustained demand for high-value replacement parts, boosting Genuine Parts' long-term growth prospects and margins. Strategic investments in digital transformation, supply chain optimization, and global expansion diversify revenue streams and enhance operational efficiency.
View narrative
US$137.43
FV
3.2% undervalued
intrinsic discount
3.48%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
34
users have followed this narrative
4 days ago
author updated this narrative
Steel Dynamics
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Domestic Reshoring And Low-carbon Investments Will Drive Long-term Metals Resilience
Key Takeaways Accelerating infrastructure, reshoring, and favorable trade policies drive strong demand, pricing power, and profit growth in steel and aluminum. Investments in sustainable production and integrated recycling enhance competitiveness, cost control, and appeal to customers seeking low-carbon materials.
View narrative
US$149.21
FV
17.6% undervalued
intrinsic discount
8.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies